Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cambrex Completes Small Scale Capacity Expansion | Contract Pharma

What are you searching for?

Sign in
Breaking News

Cambrex Completes Small Scale Capacity Expansion

Installs two 500-gallon glass lined reactors, creates a third small scale work center at Charles City, IA plant

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Cambrex Corp., a manufacturer of small molecule Active Pharmaceutical Ingredients (APIs), has completed an expansion of cGMP small scale capacity at its Charles City, IA plant.
 
The project included the installation of two 500-gallon glass lined reactors, and the creation of a third small scale work center, increasing flexibility for customer projects.
 
“Small scale manufacturing has been identified as being a crucial area where capacity is at a premium within the industry, and this investment has been undertaken to increase our flexibility and reduce potential project bottle necks to benefit our customers,” said Joe Nettleton, vice president U.S. Operations, Cambrex. “This continues Cambrex’s ongoing commitment to investing in small molecule manufacturing, ensuring that we can meet the challenges of customer project timelines, especially at the key development stages.”
 
The company also recently completed an expansion of large scale manufacturing capabilities and as well as a $24 million, 4,500 sq.-ft. highly potent API (HPAPI) manufacturing facility at Charles City, which is due to open in 2019.
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics